Author:
Miyagawa Shuji,Maeda Akira
Reference57 articles.
1. Abdel-Motal UM, Wigglesworth K, Galili U (2009) Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity. Cancer Immunol Immunother 58:1545–1556
2. Abdel-Motal UM, Wang S, Awad A, Lu S, Wigglesworth K, Galili U (2010) Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes. Vaccine 28:1758–1765
3. Blake DA, Goldstein IJ (1981) An alpha-d-galactosyltransferase activity in Ehrlich ascites tumor cells. Biosynthesis and characterization of a trisaccharide (alpha-d-galactose-(1 goes to 3)-N-acetyllactosamine). J Biol Chem 256:5387–5393
4. Blanken WM, Van den Eijnden DH (1985) Biosynthesis of terminal Gal alpha 1–3Gal beta 1–4GlcNAc-R oligosaccharide sequences on glycoconjugates. Purification and acceptor specificity of a UDP-Gal:N-acetyllactosaminide alpha 1–3-galactosyltransferase from calf thymus. J Biol Chem 260:12927–12934
5. Cho SK, Yeh JC, Cummings RD (1997) Secretion of alpha1,3-galactosyltransferase by cultured cells and presence of enzyme in animal sera. Glycoconj J 14:809–819